Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women - PubMed (original) (raw)
Randomized Controlled Trial
. 2015 Aug 14;114(3):406-17.
doi: 10.1017/S0007114515001786. Epub 2015 Jul 2.
Emmanuelle Le Chatelier 2, Edi Prifti 2, Nicolas Pons 2, Sean Kennedy 2, Trine Blædel 1, Janet Håkansson 3, Trine Kastrup Dalsgaard 4, Torben Hansen 5, Oluf Pedersen 5, Arne Astrup 1, S Dusko Ehrlich 2, Lesli H Larsen 1
Affiliations
- PMID: 26134388
- PMCID: PMC4531470
- DOI: 10.1017/S0007114515001786
Randomized Controlled Trial
Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women
Lena K Brahe et al. Br J Nutr. 2015.
Abstract
The gut microbiota has been implicated in obesity and its progression towards metabolic disease. Dietary interventions that target the gut microbiota have been suggested to improve metabolic health. The aim of the present study was to investigate the effect of interventions with Lactobacillus paracasei F19 or flaxseed mucilage on the gut microbiota and metabolic risk markers in obesity. A total of fifty-eight obese postmenopausal women were randomised to a single-blinded, parallel-group intervention of 6-week duration, with a daily intake of either L. paracasei F19 (9.4 × 1010 colony-forming units), flaxseed mucilage (10 g) or placebo. Quantitative metagenomic analysis of faecal DNA was performed to identify the changes in the gut microbiota. Diet-induced changes in metabolic markers were explored using adjusted linear regression models. The intake of flaxseed mucilage over 6 weeks led to a reduction in serum C-peptide and insulin release during an oral glucose tolerance test (P< 0.05) and improved insulin sensitivity measured by Matsuda index (P< 0.05). Comparison of gut microbiota composition at baseline and after 6 weeks of intervention with flaxseed mucilage showed alterations in abundance of thirty-three metagenomic species (P< 0.01), including decreased relative abundance of eight Faecalibacterium species. These changes in the microbiota could not explain the effect of flaxseed mucilage on insulin sensitivity. The intake of L. paracasei F19 did not modulate metabolic markers compared with placebo. In conclusion, flaxseed mucilage improves insulin sensitivity and alters the gut microbiota; however, the improvement in insulin sensitivity was not mediated by the observed changes in relative abundance of bacterial species.
Keywords: Flaxseed mucilage; Gut microbiota; Metagenomics; Obesity-related disease; Probiotics.
Figures
Fig. 1
Illustration of the 6-week parallel-group intervention, with participants randomised to one of the three different diet groups.
Fig. 2
Flow chart of the study.
Fig. 3
The presence and abundance of the thirty-three species that differed significantly before and after 6 weeks of intervention with flaxseed mucilage. Each barcode illustrates the abundance of a species, either enriched at baseline (top) or week 6 (bottom): samples are in columns (same order for both time points) and the fifty ‘tracer’ genes are in rows. Gene abundance is indicated by colour gradient from white (not detected) over blue, green and yellow to red (most abundant). Taxonomical information is given for each species; the number of genes within each metagenomic species is given in parenthesis. Fdr, Benjamini Hochberg multiple testing correction of paired Wilcoxon tests; unk., unknown taxonomy.
Similar articles
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, van Nood E, Holleman F, Knaapen M, Romijn JA, Soeters MR, Blaak EE, Dallinga-Thie GM, Reijnders D, Ackermans MT, Serlie MJ, Knop FK, Holst JJ, van der Ley C, Kema IP, Zoetendal EG, de Vos WM, Hoekstra JB, Stroes ES, Groen AK, Nieuwdorp M. Vrieze A, et al. J Hepatol. 2014 Apr;60(4):824-31. doi: 10.1016/j.jhep.2013.11.034. Epub 2013 Dec 6. J Hepatol. 2014. PMID: 24316517 Clinical Trial. - Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E, Ricart W, Fernández-Real JM. Esteve E, et al. Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21681087 Review. - Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, van Eijk HM, Venema K, Smidt H, Zoetendal EG, Dejong CHC, Lenaerts K, Blaak EE. Canfora EE, et al. Gastroenterology. 2017 Jul;153(1):87-97.e3. doi: 10.1053/j.gastro.2017.03.051. Epub 2017 Apr 8. Gastroenterology. 2017. PMID: 28396144 Clinical Trial. - Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
Chunchai T, Thunapong W, Yasom S, Wanchai K, Eaimworawuthikul S, Metzler G, Lungkaphin A, Pongchaidecha A, Sirilun S, Chaiyasut C, Pratchayasakul W, Thiennimitr P, Chattipakorn N, Chattipakorn SC. Chunchai T, et al. J Neuroinflammation. 2018 Jan 9;15(1):11. doi: 10.1186/s12974-018-1055-2. J Neuroinflammation. 2018. PMID: 29316965 Free PMC article. - GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E. Barengolts E. Endocr Pract. 2016 Oct;22(10):1224-1234. doi: 10.4158/EP151157.RA. Epub 2016 Jul 13. Endocr Pract. 2016. PMID: 27409822 Review.
Cited by
- Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: A meta-analysis of randomized controlled trials.
Cao N, Zhao F, Kwok LY, Wang H, Sun Z. Cao N, et al. Curr Res Food Sci. 2024 Jul 14;9:100810. doi: 10.1016/j.crfs.2024.100810. eCollection 2024. Curr Res Food Sci. 2024. PMID: 39114432 Free PMC article. - The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review.
Ghanbari F, Hasani S, Aghili ZS, Asgary S. Ghanbari F, et al. Food Sci Nutr. 2024 May 29;12(7):4569-4580. doi: 10.1002/fsn3.4142. eCollection 2024 Jul. Food Sci Nutr. 2024. PMID: 39055176 Free PMC article. Review. - Insights into the Anti-Adipogenic and Anti-Inflammatory Potentialities of Probiotics against Obesity.
Kober AKMH, Saha S, Ayyash M, Namai F, Nishiyama K, Yoda K, Villena J, Kitazawa H. Kober AKMH, et al. Nutrients. 2024 Apr 30;16(9):1373. doi: 10.3390/nu16091373. Nutrients. 2024. PMID: 38732619 Free PMC article. Review. - Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity.
Apalowo OE, Adegoye GA, Obuotor TM. Apalowo OE, et al. Curr Issues Mol Biol. 2024 Feb 28;46(3):1810-1831. doi: 10.3390/cimb46030119. Curr Issues Mol Biol. 2024. PMID: 38534735 Free PMC article. Review. - Unveiling the potential of linseed mucilage, its health benefits, and applications in food packaging.
Chand M, Chopra R, Talwar B, Homroy S, Singh PK, Dhiman A, Payyunni AW. Chand M, et al. Front Nutr. 2024 Feb 7;11:1334247. doi: 10.3389/fnut.2024.1334247. eCollection 2024. Front Nutr. 2024. PMID: 38385008 Free PMC article. Review.
References
- World Health Organization (2012) World Health Statistics. Geneva: WHO.
- Qin J, Li Y, Cai Z, et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60. - PubMed
- Cotillard A, Kennedy SP, Kong LC, et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588. - PubMed
- Le Chatelier E, Nielsen T, Qin J, et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical